RE: Seller17 Jun 2021 09:24
@Muck165,
I see no wording in the Admission Document that says that those two 'funds' were part of the lock-in agreement. Infact the lock-in agreement only states,
"Each of the Directors, the Company’s employees receiving shares under option schemes and certain other Shareholders, who on Admission will be the holders of 64,948,008 Ordinary Shares in aggregate, representing approximately 67.9 per cent. of the Enlarged Share Capital, (being the Locked-in Shareholders) have entered into Lock-in Agreements."
So no direct mention of which shareholders are involved.
What it does say is,
"In addition, Shareholders not subject to Lock-in Agreements, who on Admission will be the holders of
7,387,248 Ordinary Shares in aggregate, representing approximately 7.7 per cent. of the Enlarged Share
Capital, have entered into Orderly Market Agreements. Under the terms of the Orderly Market Agreements, these Shareholders have undertaken to the Company and N+1 Singer only to dispose of any interest in any Ordinary Shares owned by them or any connected person, in the period prior to the date which is twelve months from the date of Admission, through N+1 Singer during that period in such a way as to maintain an orderly market, except in certain limited circumstances considered customary for an agreement of this nature."
So those c. 7.39m shares have very much been in play since the IPO plus any others that were placed outside of the lock-in arrangement.
The fact that Touchstone hasn't sold down despite having the ability to do so is a big positive for me.
Also, one should not forget that the Chairman and CEO hold 18.5% of the company between them and are locked in until Dec 2021. That demonstrates true skin in the game and a willingness to drive the business in 2021, despite the fact that the DHSC judicial review claim was already in play prior to the IPO.
Whilst ABDX needs some good news to turn its fortunes I do feel it is about when rather than if. Yes, the share register was late in being updated but there are also valid and plausible reasons as to why a seller exists outside of the lock-in arrangement and the DHSC contract was deemed important.
My view is that the AVCT contract alone can bolster the business outlook in their new financial year (so from July) and they have other outlets for business too. 3 assays moving to large scale manufacturing remember + whatever AbC-19 can offer.
What I don't see is a conspiracy or unhand dealings. ABDX had a lot of debtors pre IPO and that does need to wash through somewhat but even then many of them have agreed to sit tight until at least the end of 2021. I'm happy to do so also.